Starting in 2026, patients covered by UnitedHealthcare's Medicare Advantage and commercial plans will not have care reimbursed for instances of remote patient monitoring unless they have diagnosed heart failure or are pregnant and experiencing hypertension. The shift stands at odds with traditional Medicare, which added new claims codes for providers to use next year.

Nasser Mohamed, MD, a neurologist who operates a clinical practice in San Francisco, said an artificial intelligence system used by the autonomous taxi company led to him being denied multiple rides. He is seeking injunctive relief.

Conductor is a platform of AI-enabled agents that can read clinical documents and orders, call patients and orchestrate appointments.

When the FDA approved elamipretide for the treatment of Barth syndrome, not everyone agreed with the agency's decision. 

Consistently incorporating unsalted peanuts into a person’s diet enhances cerebral blood flow to multiple brain regions. 

The Zuckerbergs have many billions to give away. They want to shower a lot of it on researchers using AI to cure diseases.

Noninvasive coronary CT angiography is growing more and more important as time goes on, helping cardiologists make critical treatment decisions. Carlos Collet, MD, PhD, discussed the technique's potential to be a real game-changer for patient care in a new interview. 

Taking melatonin for a year could increase a person's risk of developing heart failure by 90%. While more research is still needed to confirm these findings, the data suggest patients should think twice about relying on melatonin to sleep. 

The rise of these medications continues to be one of the biggest stories in healthcare.

Novo Nordisk and Eli Lilly have agreed to sell their popular Wegovy and Zepbound injectables through TrumpRx.gov for a discounted rate, as the White House promises that Medicaid and Medicare plans will begin covering the costs.